Finessa Ingredients: 4 Blends, Doses & Label Conflicts

Finessa ingredients are easier to judge from the published facts panel than from the sales list. This page separates named ingredients, shared blend weights and hidden doses, then explains what those details allow you to compare. For the overall decision, package prices and return process, start with the Finessa review rather than treating this label analysis as a product endorsement.

Panel group	Entries / amount	Dose detail	Identity detail	Unresolved point
Polyphenol Blend	Nine entries / 1,000 mg.	Individual weights are hidden.	Fruit and root powders plus acai extract.	The artwork associates purple carrot with Raphanus sativus; ask for corrected botanical identity.
Gut Health	Five entries / 755 mg.	Individual weights are hidden.	Cinnamon, ginger, cascara 10:1, DGL licorice and FOS.	Cascara quantity and active standardization are absent.
Liver Health Blend	Five entries / 450 mg.	Individual weights are hidden.	Dandelion, turmeric, milk thistle, artichoke and silymarin.	Two milk-thistle-related entries need clear separation.
Probiotic Blend	52.5 mg / 5 billion CFU at manufacture.	Per-strain CFU are not clearly supplied.	BC99, LA85, Bla80 and LR08 plus a mixed species list.	Front tub artwork says 3 billion CFU.
Akkermansia powder	2 mg.	Mass is given; viable count is not.	AH39 is printed.	Live or inactivated status is not established by mass.
Other ingredients	Six listed excipients.	No amounts given.	Resistant dextrin, flavors, citric acid, sea salt, stevia and silicon dioxide.	Flavor composition and allergen cross-contact need clarification.

What the blend numbers actually mean

Four blend totals add to 2,257.5 mg, with another 2 mg of Akkermansia powder listed separately. This produces 2,259.5 mg of named blend and powder mass, not the scoop’s total mass. Nutrients and excipients must not be silently omitted when estimating scoop weight or interpreting the product’s carbohydrate declaration.

The manufacturer-published panel [1] lists 10 calories, 3 g carbohydrate, selenium 1 mcg, sodium 40 mg and potassium 10 mg. These declarations are distinct from the proprietary-blend totals. Adding carbohydrate grams to blend mass would also risk double-counting ingredients that contain carbohydrate.

Group	Equal-share arithmetic	Valid conclusion
Polyphenol	1,000 ÷ 9 = 111.1 mg.	An illustrative average, not a disclosed amount.
Gut	755 ÷ 5 = 151 mg.	An illustrative average, not cascara exposure.
Liver	450 ÷ 5 = 90 mg.	An illustrative average, not the artichoke dose.

The maximum mass of any one component cannot exceed its entire blend. In practice, other ingredients occupy part of that total. Neither an average nor a ceiling identifies the actual amount. Do not calculate a daily glycyrrhizin or cascaroside dose from these figures: the required composition data are missing.

Supply creates another arithmetic problem. The facts image declares 50 servings per container; marketed purchase cards describe a 30-day tub. One scoop daily cannot make those two statements equivalent. A corrected current label and a scoop mass in grams are needed before deriving actual cost per serving.

Dose matching: artichoke provides a useful test

The 450 mg liver blend cannot hold 1,920 mg of the artichoke extract used in a published dyspepsia trial. Dividing 450 by 1,920 gives a 23.4% mass ceiling. Actual artichoke mass is lower because other ingredients share the blend, and different extracts cannot be assumed equivalent even at identical weights.

Ingredient / preparation	Published amount per scoop	Human comparison	Interpretation
Artichoke extract	Part of 450 mg liver blend; standardized to 5% cynarin.	1,920 mg/day commercial leaf extract for six weeks. Holtmann (2003), PMID: 14653829 [2]	Whole blend ceiling is 23.4% of trial extract mass; extract equivalence is unestablished.
Cascara sagrada bark extract 10:1	Part of 755 mg gut blend; individual dose absent.	LiverTox describes short-term use, generally less than one week. NIH LiverTox (2017) [3]	This is a safety duration benchmark, not a dose-matched efficacy trial.
Probiotic blend	52.5 mg; 5 billion CFU at manufacture.	Trials used different preparations. Dimidi (2014), PMID: 25099542 [4]	No justified conversion from total CFU to the effect of this mixture.
Turmeric and milk thistle	Share the 450 mg liver blend with other ingredients.	No matched Finessa preparation trial identified in the reviewed sources.	Powder mass, extract mass and active constituent mass are different measures.

Artichoke trial dose compared with the maximum amount possible within the Finessa liver blend — 450 mg entire liver blend versus 1,920 mg/day trial extract; forms differ, so this is a ceiling comparison.

Holtmann (2003) studied a defined leaf extract and a defined symptom condition. PMID: 14653829 [2]. Finessa describes whole-herb artichoke standardized to 5% cynarin. A whole-herb preparation and a trial leaf extract are not interchangeable just because both carry the same plant name. The comparison establishes a matching problem, not a precise estimate of how much benefit is lost.

If all 450 mg hypothetically were the stated 5% artichoke extract, the arithmetic ceiling would be 22.5 mg cynarin. That is not the delivered cynarin dose, because the blend includes four other entries. It also does not establish a clinical target: the trial outcome cannot be reduced to one marker percentage.

Milk thistle powder and silymarin 80% appear as separate entries. The latter’s percentage describes that ingredient, not 80% of the full liver blend. Turmeric powder likewise should not be described as a known curcumin dose. Read the effectiveness page for why preparation differences matter.

Strain codes do not resolve every probiotic question

The panel is more specific than a generic probiotic claim, but still leaves essential questions. It prints BC99, LA85, Bla80 and LR08, then a separate AH39 entry. Its 5 billion CFU footnote applies at manufacture, while the front tub artwork shows 3 billion CFU. Neither image explains the discrepancy or confirms end-of-shelf-life potency.

The probiotic section also contains a mixed species list, including a repeated L. casei entry. Preserve that wording when auditing rather than silently correcting it into a cleaner formula. The percentages alongside four strains add to 100%, but the panel does not explain whether they refer to mass, viable count or another basis.

Ask for total viable CFU guaranteed at expiry.
Request CFU per strain and the basis of the printed percentages.
Ask whether AH39 is live or inactivated and how it is standardized.
Confirm storage requirements and the current artwork version.

Dimidi (2014) pooled different probiotic preparations in constipation trials. PMID: 25099542 [4]. A total CFU count and a shared species name do not establish that Finessa reproduces a particular strain-specific outcome. Greater numerical strength also is not automatically greater clinical usefulness.

What to ask before using this label

Bring the panel and the front tub image together so a clinician can see the discrepancies. The questions are the 50-serving versus 30-day supply, 3-billion versus 5-billion CFU statements, hidden cascara dose and duration. A useful review also needs your medicines, symptoms and the reason you want a digestive supplement.

Which current label will be supplied, and what is the scoop mass?
What is the cascara amount and cascaroside standardization?
Is prolonged use appropriate with my symptoms and treatment?
Is a simpler, fully measured option suitable for my goal?

FDA explains that a supplement label and manufacturing claim do not establish premarket approval of effectiveness. FDA supplement questions [6]. Ask for an identifiable independent test report covering the current product and relevant analytes. A general facility badge is not the same as verification of this formula’s identity, strength or contaminants.

For broader context, use the dietary supplements guide, ingredient library and Dietary Supplement Reviews. The complaints page explains what records help resolve a labeling or return dispute.

Frequently asked questions

How many ingredients are in Finessa?

The panel has nine polyphenol entries, five gut entries and five liver entries, plus a complex probiotic listing, separate Akkermansia, nutrients and six other ingredients. A single headline count would hide duplicated or grouped organisms. Use the complete panel rather than treating eight sales highlights as the full formula.

Does 450 mg mean 450 mg artichoke?

No. That amount is the entire liver blend, which lists five entries. The actual artichoke quantity is hidden. Dividing by five produces an illustrative average only. A 5% cynarin description applies to the artichoke extract and does not reveal how much extract is present.

Does the panel disclose probiotic strains?

It prints several strain codes, including BC99, LA85, Bla80, LR08 and separate AH39. That is useful identity information, but per-strain viable counts and expiry potency remain unclear. The mixed species list and front-artwork CFU discrepancy also need clarification before a precise evidence match.

Is the licorice deglycyrrhizinated?

The published panel describes deglycyrrhizinated licorice extract. Do not rewrite it as an ordinary licorice preparation. However, the individual dose and residual glycyrrhizin are not supplied, and this detail does not establish the safety of cascara or the other ingredients in the same mixture.

Can I use several scoops to match a trial?

Do not increase the serving to imitate an unrelated study. Every scoop increases the other ingredients too, including an undisclosed cascara dose. Trial extract, botanical part and population also differ. A clinician should assess a suitable preparation rather than reverse-engineering treatment from a blend ceiling.

Request the current Finessa label and directions →

Explore the Finessa audit series

Author and research method

Biraj Health Care is the editorial identity of Biraj K. (M.Ed. in Health Education, Tribhuvan University). For this ingredient analysis, the published facts panel was compared with human artichoke research, probiotic evidence and official ingredient guidance, checked October 29, 2026. It does not represent a personal product trial or independent laboratory testing.

Methodology · Sources policy · Author profile · Supplement guide · Ingredient library · Dietary Supplement Reviews

Finessa Ingredients: What the Published Label Actually Discloses